
OrthoPediatrics (KIDS) Stock Forecast & Price Target
OrthoPediatrics (KIDS) Analyst Ratings
Bulls say
OrthoPediatrics is well-positioned for long-term growth and profitability, as shown by their robust pipeline of innovative products still in development, and their successful track record of taking market share from larger competitors. Additionally, the company's exclusive focus on pediatric orthopedics and global distribution in over 70 countries outside the US solidifies their position as a leading player in this niche market. Moreover, strong distributor sentiment and surgeon demand for KIDS' Super Cycle products bode well for potential upside in revenue and operating leverage in the coming years.
Bears say
OrthoPediatrics is a medical device company that specializes in products for the pediatric orthopedic market, including implants and instruments. However, their focus on the pediatric market leaves them vulnerable to competition from larger players in the orthopedic industry. Additionally, the company's stocks are trading at depressed levels despite a solid growth rate. Risks to the stock include competition, slow product pipeline, and lack of intellectual property.
This aggregate rating is based on analysts' research of OrthoPediatrics and is not a guaranteed prediction by Public.com or investment advice.
OrthoPediatrics (KIDS) Analyst Forecast & Price Prediction
Start investing in OrthoPediatrics (KIDS)
Order type
Buy in
Order amount
Est. shares
0 shares